Zofran

Thousands of pregnant women across the United States were prescribed Zofran as a treatment for morning sickness. However, this medication was never approved by the Food and Drug Administration (FDA) as safe for use by expectant mothers. Today, many women are speaking up about birth defects that they claim were caused by the medication.

The drug was originally approved in 1991 as an anti-nausea drug for cancer patients. It reduced the urge to vomit and made chemotherapy more bearable for patients. Doctors started prescribing the drug to their pregnant patients to fight morning sickness when the FDA-approved medication Bendectin was pulled from the market. While the drug might have been effective for cancer patients, it was never tested for pregnant women or labeled safe for use by expecting mothers.   

As a result of taking Zofran, many women claim their babies developed a variety of birth defects, including cleft palates and cleft lips, congenital heart defects, kidney malformations, and skull deformities. Not only do these birth defects require immediate surgeries for the newborns, they also require years of care, therapy, medication, and treatment for some of the infants. The parents can expect a lifetime of healthcare bills and high costs because of this drug.

Parents across the country are speaking up to protect future babies from the same fate. There are currently more than 500 lawsuits against GlaxoSmithKline (the maker of Zofran) pending in federal courts regarding the birth defects. These plaintiffs are fighting to cover their medical expenses and the trauma their families have faced as a result of Zofran.

If your child has birth defects as a result of your taking Zofran as a morning sickness treatment, then you can join the list of lawsuits against GlaxoSmithKline.

Contact Ralph M. Guito III, your personal injury lawyer, for help filing a claim. All of our consultations are free, and you won’t pay unless you win.